Articles from Caixin Global, Caixin Global

Caixin Global

Articles from Caixin Global

Caixin is a media group dedicated to providing financial and business news through periodicals, online content, mobile apps, conferences, books and TV/video programs. Caixin aims to blaze a trail that helps traditional media prosper in the new media age through integrated multimedia platforms.

News from Caixin

Cross Asset Strategy

<ul><li><p>Cover Story: The Covid-fighting struggle of China’s nursing homes</p></li><li><p>Beijing probes whether hospital Covid protocols contributed to man’s death</p></li><li><p>China draws from next year’s budget for local government handouts</p></li></ul>

Cover Story: The Covid-fighting struggle of China’s nursing homesBeijing probes whether hospital Covid protocols contributed to man’s deathChina draws from next year’s budget for local government handouts

CX Daily: The Covid-Fighting Struggle of China’s Nursing Homes

Chief Economist

Diana Choyleva

Enodo Economics

Enodo Economics is an independent macroeconomic forecasting company that untangles complexity, challenges the consensus, and makes sense of the future. Our focus is on China – one of the most misunderstood economies in the world, but one of the most important to figure out.  Enodo’s chief economist, Diana Choyleva, has been analysing China for almost 20 years, while Enodo’s team boasts a combined 140 years’ experience covering China’s economy, politics and markets. 

Macroeconomics

<h2><strong>China News That Matters</strong></h2>
<ul>
<li>Concessions all round in US-China trade talks</li>
<li>Huawei “stealing its way” to global dominance?</li>
<li>Consumers flip credit cards and listed firms lie</li>
<li>Laud this student protest. Ignore the one next month</li>
</ul>
<div class="content-remarks">
<p>In my weekly digest China News That Matters, I will give you selected summaries, sourced from a variety of local Chinese-language and international news outlets, and highlight why I think the news is significant. These posts are meant to neither be bullish nor bearish, but help you separate the signal from the noise.</p>
</div>

China News That Matters

Concessions all round in US-China trade talks
Huawei “stealing its way” to global dominance?
Consumers flip credit cards and listed firms lie
Laud this student protest. Ignore the one next month


In my weekly digest China News That Matters, I will give you selected summaries, sourced from a variety of local Chinese-language and international news outlets, and highlight why I think the news is significant. These posts are meant to neither be bullish nor bearish, but help you separate the signal from the noise.


Trade War/Huawei/Financial Risks/Mr Science & Mr Democracy

Index Rebal/Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Index Rebal/Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

Index Rebalance

<ul>
<li>CSI 1000 represents the next 1000 largest stocks by market cap and liquidity from the Shanghai and Shenzhen Exchanges after CSI 800.</li>
<li>There were 6 intra-review ad hoc changes announced for the CSI 1000 index this week due to some index constituents being labeled "Special Treatment" companies (covered in QIPS yesterday).</li>
<li>Here we present our final expectations for ADDs and DELs for the upcoming semiannual index rebal event in June 2026. We expect 100 ADDs/DELs. There are our final expectations.</li>
</ul>


CSI 1000 represents the next 1000 largest stocks by market cap and liquidity from the Shanghai and Shenzhen Exchanges after CSI 800.
There were 6 intra-review ad hoc changes announced for the CSI 1000 index this week due to some index constituents being labeled "Special Treatment" companies (covered in QIPS yesterday).
Here we present our final expectations for ADDs and DELs for the upcoming semiannual index rebal event in June 2026. We expect 100 ADDs/DELs. There are our final expectations.


Quiddity Leaderboard CSI 1000 Jun26: Ad Hoc Changes Announced; Final Expectations Post-Adjustment

Analyst

Alasdair Moody

Exposing Creative Accounting

Bucephalus Research Partnership

Bucephalus Research Partnership Limited. Exposing Creative Accounting.

At the Bucephalus Research Partnership (BRP) we analyse financial statements using our accountant's practical experience and our own quantitative algorithms for corporate governance, accounting risk and peer performance.

Our thematic research refines our unique algorithms while our single stock research focuses on examples where we discover a significant gap between published accounts and business reality.

​Bucephalus Research Partnership:
- Is an independent fee-based research service
- Does not take proprietary positions, long or short
- Does not solicit business or fees from the corporates we review

Thematic (Sector/Industry)

<p>We examined ten years of accounting and valuation data for the pharmaceutical companies around the world with sales of US$100m+ and created statistics for each region based on aggregate data and for a typical company. In this trend report, we summarise the data and highlight the outliers. Assuming clients will have their own macro industry views, we used valuations and our Governance, Accounting risk and Peer performance (GAP) scores, (which help quantify the risk of creative accounting) to…</p>

We examined ten years of accounting and valuation data for the pharmaceutical companies around the world with sales of US$100m+ and created statistics for each region based on aggregate data and for a typical company. In this trend report, we summarise the data and highlight the outliers. Assuming clients will have their own macro industry views, we used valuations and our Governance, Accounting risk and Peer performance (GAP) scores, (which help quantify the risk of creative accounting) to…

Global Pharmaceuticals: Valuations, Assets and Leverage Up - Margins Down

Making sense of the Global Market, Euromonitor International Ltd.

Yu Mitsuhashi

Making sense of the Global Market

Euromonitor International Ltd.

We are a global market research company focused on industries, countries, economies and consumers worldwide. Our cross-country comparable research helps your organisation identify opportunities and develop growth strategies in countries and regions across the globe. With offices around the world, 1,200 analysts in 100 countries and market research on every key trend and driver, we give you powerful access to the real story behind consumer change.

<p>While the US consumer health industry will remain a strong centre for investment, development and technology innovation in 2017 and is expected to reach US$77 billion by 2021, the election of Donald Trump has created uncertainty among the industry, government agencies and consumers, especially around regulations, local production incentives, and changes to the Affordable Care Act.</p>

While the US consumer health industry will remain a strong centre for investment, development and technology innovation in 2017 and is expected to reach US$77 billion by 2021, the election of Donald Trump has created uncertainty among the industry, government agencies and consumers, especially around regulations, local production incentives, and changes to the Affordable Care Act.

Trump Health Effect: What Is Next for the Consumer Health Industry Under Trump's Leadership?

China

Kangmei Pharmaceutical Co., Ltd. develops, produces, and sells medicines that are used for the treatment of high blood pressure and cold.  The Company also pr oduces antibiotic drugs and health care products. Kangmei also sells other manufacturers' medical products through its wholesale and retail chain.

Kangmei Pharmaceutical Co Ltd (600518 CH)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Kangmei Pharmaceutical Co Ltd (600518 CH)

CX Daily: The Covid-Fighting Struggle of China’s Nursing Homes

Cover Story: The Covid-fighting struggle of China’s nursing homes. Beijing probes whether hospital Covid protocols contributed to man’s death

Caixin Global

Trade War/Huawei/Financial Risks/Mr Science & Mr Democracy

China News That Matters Concessions all round in US-China trade talks Huawei “stealing its way” to global dominance? Consumers flip credit cards...

Diana Choyleva

Quiddity Leaderboard CSI 1000 Jun26: Ad Hoc Changes Announced; Final Expectations Post-Adjustment

The CSI 1000 index could see US$1.6bn one-way flows during the June 2026 index rebal event. The ADDs/DELs could be confirmed after market close on...

Janaghan Jeyakumar, CFA

Global Pharmaceuticals: Valuations, Assets and Leverage Up - Margins Down

We examined ten years of accounting and valuation data for the pharmaceutical companies around the world with sales of US$100m+ and created...

Bucephalus Research Partnership

Trump Health Effect: What Is Next for the Consumer Health Industry Under Trump's Leadership?

While the US consumer health industry will remain a strong centre for investment, development and technology innovation in 2017 and is expected to...

Euromonitor International Ltd.

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)